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Status epilepticus (SE) is a medical emergency that 
requires immediate identification and treatment. Despite 
extensive research, it continues to be a major clinical 
problem throughout the world, with high rates of inci- 
dence (approximately 40 per 100,000) and mortality (ap- 
proximately 26% in adults and 3% in children) (1). How- 
ever, a number of new insights into the pathogenesis and 
treatment of SE have improved our understanding and 
overall clinical management of this condition. This 
supplement reviews the most up-to-date experimental 
and clinical research on the diagnosis and treatment of 
SE in children and adults. 
Several important and complex issues relative to the 
definition of status epilepticus must be addressed if we 
are to understand its underlying pathogenesis and de- 
velop effective treatments. In an overview, Dr. Daniel 
Lowenstein describes the history of SE and the evolution 
of its definition. For many years, investigators have 
struggled to identify a specific seizure duration param- 
eter that defines the onset of SE. The "textbook" defini- 
tion of SE cites seizure duration of 230 min, indicating 
the point at which seizure-induced neuronal injury be- 
gins. However, there are currently no data that clearly 
support this time interval. The exact duration of seizures 
that establishes SE remains uncertain and difficult to 
ascertain. Therefore, Dr. Lowenstein discusses the ratio- 
nale for using an operational definition of SE that is 
distinct from a mechanistic definition. The role of un- 
derlying etiology, duration of seizures, and age as sig- 
nificant determinants of outcome of SE are reviewed as 
well. 
Under normal circumstances, individuals will have a 
seizure that is self-terminating, but when the mechanisms 
of termination fail the seizure becomes prolonged. My 
article examines the pathophysiologic mechanisms oc- 
curring in the hippocampus during an acute episode of 
SE. Although the mechanisms at work during the tran- 
sition between a self-terminating seizure and the pro- 
longed duration of SE remain unknown, several theories 
on the pathophysiology of SE have evolved: (a) the hip- 
pocampus is consistently activated during SE; (b) loss of 
y-aminobutyric acid (GABA)-mediated inhibitory syn- 
aptic transmission in the hippocampus is a crucial com- 
ponent in the emergence of SE; and (c) glutamatergic 
excitatory synaptic transmission is an important factor 
during SE. The focal point of this discussion will be on 
the alteration of GABAergic inhibition in the hippocam- 
pus and other areas of the brain that occurs during the 
prolonged seizures of SE. 
Because SE is not a singular entity, it is often followed 
by severe forms of morbidity, the most common of 
which is the development of seizures. The long-term 
consequences of SE are the topic of two presentations. 
First, Dr. Douglas Coulter discusses the chronic changes 
that occur in experimental animals after prolonged sei- 
zures. An association between seizures originating from 
or involving the limbic system and an ensuing partial 
epilepsy has been demonstrated through the development 
of animal models of temporal lobe epilepsy. These mod- 
els involve triggering an episode of SE in an experimen- 
tal animal, leading to the eventual development of recur- 
rent spontaneous seizures of limbic origin. Dr. Coulter 
reviews the distinct patterns of cell loss, circuit rear- 
rangements, alterations in GABAergic function, and 
other changes that are evident in the epileptic hippocam- 
pus of experimental animals. In addition, Dr. Coulter 
explores the implications of duplicating experiments in- 
volving animal models of temporal lobe epilepsy by con- 
ducting studies of the limbic tissue of humans with epi- 
lepsy. 
Dr. Robert Sloviter then discusses the potential role of 
SE-induced neuronal injury and network reorganization 
in the subsequent development of mesial temporal scle- 
rosis. Episodes of SE or prolonged febrile seizures in 
childhood may be a contributing factor in the epilepto- 
genic process leading to temporal lobe epilepsy. It is 
possible that an unidentified preexisting defect is respon- 
sible for both SE and epilepsy, and that no causal rela- 
tionship exists between the two events. However, the 
mechanisms by which prolonged seizures trigger epilep- 
togenesis, if in fact they do, are not yet clear and present 
a challenge for future studies. 
Issues that must be addressed concerning the occur- 
rence of prolonged seizures in the pediatric population 
differ from those in adults. Dr. Eli Mizrahi discusses 
clinical issues associated with the acute and chronic ef- 
fects of SE on the developing brain, using the neonate as 
an example. Seizures in the neonate are frequently con- 
sidered a form of SE because of their prolonged duration, 
the difficulty involved in controlling them with antiepi- 
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leptic drugs, and their association with severe morbidity 
and mortality due to underlying brain disorders. There 
remains to be a clear understanding of how seizures af- 
fect the developing brain, even though basic neurosci- 
ence and clinical research have addressed these issues. 
Current clinical studies indicate that there are several 
predominant factors in determining long-term outcome 
of neonates with prolonged seizures. However, the ef- 
fects of CNS injury that accompany the onset of neonatal 
seizures may be difficult to distinguish from the effects 
of the seizures themselves or their treatment. Therefore, 
clinical studies must be designed to apply methodology 
that is sensitive enough to identify seizure-induced in- 
jury. 
Dr. Frances Jensen explores the acute and chronic ef- 
fects of prolonged seizures on the developing brain of 
experimental models. This article reviews recent experi- 
mental data that may provide answers to questions con- 
cerning clinical epileptology, as well as new insights into 
possible mechanisms of seizure-induced injury in the de- 
vel oping brain. 
Lastly, Dr. Thomas Bleck discusses the problem of 
treating SE, providing up-to-date results of ongoing 
clinical trials and describing his approach to treating SE 
in the hospital setting. 
Future studies and research will, in all likelihood, 
identify accurate methods for recognizing the important 
factors that differentiate a single seizure from SE. A 
thorough understanding of the events that lead to the 
development, preservation, and cytotoxicity of status 
epilepticus should result in more effective treatment 
strategies and reduced mortality and morbidity in the 
future. 
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